'Oncology drugs' presentation slideshows

Protocol Development Outline

832 views • 43 slides

Natco Sorafenib Price India | Nexavar 200mg USA , UK Supply | Kidney Cancer Drugs

Get Sorafenib 200mg tablets online including its brand Sorafenat , Soranib , Nexavar at most affordable rates with its Price , precautions , storage , uses @drugssquare.com USA , UK , Russia , South Africa Supplier

294 views • 14 slides

Oncology Drugs Global Market Report 2018

The global oncology drugs market was valued around $126 billion in 2017. North America was the largest region in the oncology drugs market in 2017, accounting for around 30% of the total market. Read Report https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report-2018

155 views • 12 slides

Global Oncology/Cancer Drugs Market (Therapeutic Modalities,

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market

347 views • 11 slides

Oncology/Cancer Drugs Market - Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity.

395 views • 11 slides

Generic Oncology Drugs Market is poised to striking CAGR of 6% by 2028

Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of growth for the generic oncology drugs market and the cost pertaining to the treatment of cancer. Advanced technologies such as real world data, mobile apps, and artificial intelligence have successfully been able to achieve a high engagement rate of the patients, which has resulted in increasing awareness of the cancer treatment among the patients.

87 views • 8 slides

Generic Oncology Drugs Market to Display Growth at a CAGR of 6.2% in 2028

Increasing incidences of cancer have been detected, ascending from the proclivity for cigarettes and tobacco among individuals. The number of cancer-infected patients is stimulated by viral infections, carcinogens, lack of physical activities, genetic causes, age, and unhealthy eating habits. Recent developments in the healthcare sector have broadened the scope of therapies for the treatment of cancer by leveraging oncology.

87 views • 8 slides

Global Oncology Drugs Industry 2013-2018: Trend, Profit, and

The global oncology drugs industry experienced significant growth during the past five years and is expected to continue that momentum to reach an estimated $100.6 billion in 2018.

198 views • 7 slides

Global Oncology Drugs Market - Competitive Analysis And Revenue Growth

Oncology drugs and medications have become a blooming business for players in the pharmaceutical industry.

52 views • 5 slides